Have your own idea? Try our Stock Screener
Bangladeshi (DSE) Healthcare Sector Analysis
UpdatedJun 07, 2026
DataAggregated Company Financials
Companies23
- 7D1.7%
- 3M8.0%
- 1Y11.1%
- YTD12.4%
In the last week, the Healthcare industry is up 1.7%, with Beximco Pharmaceuticals up 2.7%. This takes the industry's 12 month performance to a gain of 11%. Earnings are forecast to grow by 15% annually.
Sector Valuation and Performance
Has the Bangladeshi Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 08 Jun 2026 | ৳412.3b | ৳268.0b | ৳40.3b | 28.5x | 10.2x | 1.5x |
| Wed, 06 May 2026 | ৳400.3b | ৳266.3b | ৳40.2b | 21x | 10x | 1.5x |
| Fri, 03 Apr 2026 | ৳394.1b | ৳260.5b | ৳39.5b | 23.1x | 10x | 1.5x |
| Sun, 01 Mar 2026 | ৳419.1b | ৳260.5b | ৳39.5b | 20.5x | 10.6x | 1.6x |
| Tue, 27 Jan 2026 | ৳389.2b | ৳256.7b | ৳38.6b | 18.8x | 10.1x | 1.5x |
| Thu, 25 Dec 2025 | ৳370.4b | ৳254.4b | ৳38.3b | 18.7x | 9.7x | 1.5x |
| Sat, 22 Nov 2025 | ৳368.9b | ৳249.5b | ৳36.8b | 18.5x | 10x | 1.5x |
| Mon, 20 Oct 2025 | ৳392.1b | ৳245.7b | ৳37.1b | 19.9x | 10.6x | 1.6x |
| Wed, 17 Sep 2025 | ৳428.0b | ৳245.7b | ৳37.1b | 24.4x | 11.5x | 1.7x |
| Fri, 15 Aug 2025 | ৳419.0b | ৳245.7b | ৳37.1b | 22.2x | 11.3x | 1.7x |
| Sun, 13 Jul 2025 | ৳389.0b | ৳245.7b | ৳37.1b | 21.4x | 10.5x | 1.6x |
| Tue, 10 Jun 2025 | ৳369.4b | ৳245.7b | ৳37.1b | 20.3x | 10x | 1.5x |
| Thu, 08 May 2025 | ৳379.2b | ৳243.7b | ৳37.1b | 19x | 10.2x | 1.6x |
| Sat, 05 Apr 2025 | ৳404.2b | ৳239.9b | ৳36.2b | 20.8x | 11.2x | 1.7x |
| Mon, 03 Mar 2025 | ৳395.7b | ৳239.8b | ৳36.2b | 21.6x | 10.9x | 1.6x |
| Wed, 29 Jan 2025 | ৳394.0b | ৳235.6b | ৳34.6b | 20.9x | 11.4x | 1.7x |
| Fri, 27 Dec 2024 | ৳415.6b | ৳233.9b | ৳34.8b | 22.5x | 11.9x | 1.8x |
| Sun, 24 Nov 2024 | ৳410.6b | ৳227.8b | ৳34.5b | 22.4x | 11.9x | 1.8x |
| Tue, 22 Oct 2024 | ৳407.8b | ৳227.4b | ৳32.8b | 18.8x | 12.4x | 1.8x |
| Thu, 19 Sep 2024 | ৳451.8b | ৳229.2b | ৳32.8b | 27.2x | 13.8x | 2x |
| Sat, 17 Aug 2024 | ৳468.3b | ৳229.2b | ৳32.8b | 29x | 14.3x | 2x |
| Mon, 15 Jul 2024 | ৳463.9b | ৳229.2b | ৳32.8b | 29.4x | 14.2x | 2x |
| Wed, 12 Jun 2024 | ৳419.7b | ৳226.5b | ৳32.6b | 29.1x | 12.9x | 1.9x |
| Fri, 10 May 2024 | ৳478.2b | ৳223.8b | ৳32.7b | 33.9x | 14.6x | 2.1x |
| Sun, 07 Apr 2024 | ৳476.2b | ৳220.5b | ৳31.6b | 29.9x | 15.1x | 2.2x |
| Tue, 05 Mar 2024 | ৳515.3b | ৳220.5b | ৳31.5b | 35.1x | 16.4x | 2.3x |
| Thu, 01 Feb 2024 | ৳547.4b | ৳217.4b | ৳31.5b | 29.5x | 17.4x | 2.5x |
| Sat, 30 Dec 2023 | ৳549.9b | ৳214.4b | ৳31.1b | 28.9x | 17.7x | 2.6x |
| Mon, 27 Nov 2023 | ৳548.9b | ৳214.5b | ৳31.2b | 32.3x | 17.6x | 2.6x |
| Wed, 25 Oct 2023 | ৳550.4b | ৳207.1b | ৳32.0b | 35.5x | 17.2x | 2.7x |
| Fri, 22 Sep 2023 | ৳550.6b | ৳206.7b | ৳32.0b | 37.6x | 17.2x | 2.7x |
| Sun, 20 Aug 2023 | ৳549.9b | ৳206.7b | ৳32.0b | 37.6x | 17.2x | 2.7x |
| Tue, 18 Jul 2023 | ৳553.7b | ৳206.3b | ৳32.0b | 36.8x | 17.3x | 2.7x |
| Thu, 15 Jun 2023 | ৳550.0b | ৳206.2b | ৳32.1b | 37.1x | 17.1x | 2.7x |
Price to Earnings Ratio
17.1x
Current Industry PE
- Investors are pessimistic on the Bangladeshi Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 10.2x which is lower than its 3-year average PE of 13.1x.
- The 3-year average PS ratio of 1.9x is higher than the industry's current PS ratio of 1.5x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 7.8% per year over the last three years.
- Revenues for these companies have grown 9.1% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Bangladeshi Healthcare sector?
| BD Market | 2.17% | |
| Healthcare | 1.69% | |
| Biotech | 13.04% | |
| Medical Equipment | 3.88% | |
| Pharma | 1.62% | |
| Healthcare Services | 0.57% | |
Industry PE
- Investors are most optimistic about the Healthcare Services industry even though it's trading below its 3-year average PE ratio of 195x.
- It looks like they are confident that earnings will grow faster in the future than they have historically.
- Investors are most pessimistic about the Pharma industry, which is trading below its 3-year average of 12.7x.
Forecasted Growth
- Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 15% over the next 5 years.
- This is better than its past earnings growth rate of 10% per year.
- In contrast, the Pharma industry is expected to see its earnings grow by 15% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BXPHARMA Beximco Pharmaceuticals | ৳125.30 | 2.7% +৳1.5b | 43.4% | PE8.8x | |
| SQURPHARMA Square Pharmaceuticals | ৳212.90 | 0.5% +৳975.1m | 5.0% | PE7.3x | |
| ASIATICLAB Asiatic Laboratories | ৳136.00 | 4.2% +৳673.2m | 312.1% | PE44x | |
| ACMELAB ACME Laboratories | ৳79.40 | 3.8% +৳613.6m | 13.4% | PE6.3x | |
| BEACONPHAR Beacon Pharmaceuticals | ৳104.00 | 2.3% +৳531.3m | -1.0% | PE19.4x |